December 18, 2024

Larotrectinib in Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors

In a Children’s Oncology Group study (ADVL1823) reported in Journal of Clinical Oncology, Laetsch et al evaluated the role of larotrectinib in patients with newly diagnosed infantile fibrosarcoma and ...

The ASCO Post

December 18, 2024

Does Anger at Health Care Drive Change?

In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.

KFF Health News

December 18, 2024

FDA Approves Mesoblast's Therapy for GVHD

FDA approves Mesoblast's cell therapy for treating graft-versus-host disease after stem cell or bone marrow transplants.

Reuters

December 17, 2024

Pfizer: No Major Vaccine Shifts in 2025

Pfizer's CEO addressed the impact of potential vaccine policy changes and the nomination of a vaccine skeptic to run the Department of Health and Human Services, highlighting the company's commitment to advancing the right policies and overcoming challenges in the pharmaceutical market.

Reuters

December 16, 2024

Probiotics' Limits Revealed in Major Review

"Current evidence does not support the notion that probiotics can restore the microbiota to its pre-antibiotic state."

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

December 16, 2024

New Drug Cuts Steroid Need in CAH

The FDA has approved crinecerfont (Crenessity) to manage androgen levels in classic congenital adrenal hyperplasia in individuals aged 4 or older. Find out more at FDA.

Conexiant

December 12, 2024

Key Genetic Variants in Palmoplantar Keratoderma

In a Danish cohort of 142 patients with palmoplantar keratoderma, researchers identified DSP variants linked to cardiomyopathy risk in seemingly typical cases, highlighting why genetic testing matters beyond just diagnosis.

Conexiant

December 11, 2024

Study Links cfDNA Sequencing to Cancer Detection

Nearly 50% of pregnant participants with abnormal cell-free DNA sequencing results were found to have undiagnosed cancers, highlighting the potential of prenatal cell-free DNA screening to detect occult cancers.

Conexiant